Home » Topics » BioWorld

BioWorld
RSS

UNEVENTFUL DAY FOR STOCKS

April 9, 1992

GENSIA CORONARY ADJUNCT ENTERS PHASE III

April 9, 1992

WATSON MAY RESIGN IN NIH DISPUTE

April 9, 1992

FDA TO REVIEW IMAGING AGENT

April 9, 1992

BIG NAMES BOLSTER ICOS OFFERING

April 9, 1992

GENZYME, XENOVA TO COLLABORATE

April 9, 1992

DEAL TO DELAY UBS STOCK DISTRIBUTION

April 8, 1992

MARKET UNDERTOW GRABS BIOTECH STOCKS

April 8, 1992

OPTIMISM ON CENTOXIN ISN'T UNANIMOUS

April 8, 1992

PATENT ON POSITIVE IMAGING TECHNIQUE

April 8, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...